Ge Long Hui·2026-01-14 04:30Group 1 - The core viewpoint of the article highlights the strong performance of AI healthcare stocks in the Hong Kong market, driven by clear industry trends and significant demand for health AI solutions [1] - Alibaba Health led the surge with a rise of over 13%, accumulating a monthly increase of over 46%, while other companies like Yidu Tech and MicroPort Robotics also saw substantial gains [1] - The launch of Ant Group's AI health assistant "Ant Aifu," which quickly surpassed 30 million monthly active users and received over 10 million daily inquiries, underscores the massive demand and market potential for health AI [1] Group 2 - OpenAI's introduction of "ChatGPT Health" on January 8 further indicates that leading AI companies are optimistic and heavily investing in the health AI sector [1] - Frost & Sullivan predicts that China's "AI + healthcare" market will grow from 8.8 billion yuan in 2023 to 315.7 billion yuan by 2033, with a compound annual growth rate of 43.1% over the next decade [1] - Huafu Securities' latest report states that the AI healthcare industry has entered a critical phase of commercialization, supported by national strategies and market demand [1]